Cargando…

Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect

Macrophages participate in many links in the pathological process of atherosclerosis (AS) and the regulation of influence of macrophages at the molecular level might be a new avenue for AS treatment. For this aim, the macrophage membrane biomimetic nanoparticles, derived from macrophage membrane coa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sha, Xuan, Dai, Yue, Chong, Lijuan, Wei, Min, Xing, Mengyuan, Zhang, Chun, Li, Jingjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714205/ https://www.ncbi.nlm.nih.gov/pubmed/36456996 http://dx.doi.org/10.1186/s12951-022-01720-2

Ejemplares similares

Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis
por: Flores, Alyssa M., et al.
Publicado: (2020)

Efferocytic Defects in Early Atherosclerosis Are Driven by GATA2 Overexpression in Macrophages
por: Yin, Charles, et al.
Publicado: (2020)

The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis
por: Jarr, Kai-Uwe, et al.
Publicado: (2022)

Resolution therapy: Harnessing efferocytic macrophages to trigger the resolution of inflammation
por: Saas, Philippe, et al.
Publicado: (2022)

Inhaled Pro‐Efferocytic Nanozymes Promote Resolution of Acute Lung Injury
por: Ji, Haiying, et al.
Publicado: (2022)

Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications
por: Wang, Yi, et al.
Publicado: (2021)

Bacillus anthracis Edema Toxin Inhibits Efferocytosis in Human Macrophages and Alters Efferocytic Receptor Signaling
por: Pan, Zijian, et al.
Publicado: (2019)

Complement Component C1q Programs a Pro-Efferocytic Phenotype while Limiting TNFα Production in Primary Mouse and Human Macrophages
por: Hulsebus, Holly J., et al.
Publicado: (2016)

Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers
por: Grabiec, Aleksander M, et al.
Publicado: (2018)

Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes
por: Lam, Austin Le, et al.
Publicado: (2021)

Targeted Therapy of Atherosclerosis Vulnerable Plaque by ROS-Scavenging Nanoparticles and MR/Fluorescence Dual-Modality Imaging Tracing
por: Dai, Yue, et al.
Publicado: (2022)

Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles
por: Chong, Lijuan, et al.
Publicado: (2023)

Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines
por: Gao, Cheng, et al.
Publicado: (2020)

Klebsiella pneumoniae infection of murine neutrophils impairs their efferocytic clearance by modulating cell death machinery
por: Jondle, Christopher N., et al.
Publicado: (2018)

Biomimetic 3D Models for Investigating the Role of Monocytes and Macrophages in Atherosclerosis
por: Garcia-Sabaté, Anna, et al.
Publicado: (2020)

Biomimetic piezoelectric nanocomposite membranes synergistically enhance osteogenesis of deproteinized bovine bone grafts
por: Bai, Yunyang, et al.
Publicado: (2019)

Oral membrane-biomimetic nanoparticles for enhanced endocytosis and regulation of tumor-associated macrophage
por: Gu, Xiaoyan, et al.
Publicado: (2023)

Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023)

Synergistic Photothermal-Chemotherapy Based on the Use of Biomimetic Magnetic Nanoparticles
por: Jabalera, Ylenia, et al.
Publicado: (2021)

The Opportunities and Challenges of Silica Nanomaterial for Atherosclerosis
por: Sha, Xuan, et al.
Publicado: (2021)

Biomimetic Cucurbitacin B-Polydopamine Nanoparticles for Synergistic Chemo-Photothermal Therapy of Breast Cancer
por: Leng, Junke, et al.
Publicado: (2022)

ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis
por: Tang, Dan, et al.
Publicado: (2021)

Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) mice
por: Wang, Qi, et al.
Publicado: (2021)

Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023)

Cell membrane-derived biomimetic nanodecoys for viruses
por: Liu, Xuan, et al.
Publicado: (2020)

Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment
por: Wu, Yuesong, et al.
Publicado: (2022)

Biomimetic Lipopolysaccharide‐Free Bacterial Outer Membrane‐Functionalized Nanoparticles for Brain‐Targeted Drug Delivery
por: Chen, Haiyan, et al.
Publicado: (2022)

Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics
por: Zhang, Minghai, et al.
Publicado: (2021)

Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles
por: Liu, Lizhi, et al.
Publicado: (2021)

Nanobiotechnology of Biomimetic Membranes
por: Martin, Donald K
Publicado: (2007)

Inflammation and Microbiota Regulation Potentiate Pneumonia Therapy by Biomimetic Bacteria and Macrophage Membrane Nanosystem
por: Li, Yuan, et al.
Publicado: (2023)

Neutrophil membrane biomimetic delivery system (Ptdser‐NM‐Lipo/Fer‐1) designed for targeting atherosclerosis therapy
por: Li, Wei, et al.
Publicado: (2023)

Bioelectrochemistry of biomembranes and biomimetic membranes
por: Guidelli, Rolando
Publicado: (2016)

Challenges in Commercializing Biomimetic Membranes
por: Perry, Mark, et al.
Publicado: (2015)

Effects of Capsaicin on Biomimetic Membranes †
por: Sharma, Neha, et al.
Publicado: (2019)

Cell-derived biomimetic nanoparticles as a novel drug delivery system for atherosclerosis: predecessors and perspectives
por: Yang, Long, et al.
Publicado: (2020)

Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis
por: Zhu, Li, et al.
Publicado: (2023)

Biomimetic electrodynamic nanoparticles comprising ginger-derived extracellular vesicles for synergistic anti-infective therapy
por: Qiao, Zhuangzhuang, et al.
Publicado: (2022)

Ironing out macrophages in atherosclerosis: Ironing out macrophages in atherosclerosis
por: Wang, Lei, et al.
Publicado: (2023)

Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery
por: Wang, Haijun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q3o3ip4jdhabitaifbo1g61mkk